Wells Fargo & Company 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-25 10:43 am Sale | 2024-09-30 | 13G | Lumos Pharma, Inc. LUMO | WELLS FARGO & COMPANY WFC | 64,981 0.800% | -352,070 (-84.42%) | Filing |
| 2024-02-06 09:57 am Purchase | 2023-12-31 | 13G | Lumos Pharma, Inc. LUMO | WELLS FARGO & COMPANY WFC | 417,051 5.300% | 417,051 (New Position) | Filing |